1
Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings
Condition(s):Opioid-Related DisordersLast Updated:June 16, 2020Completed
Vivitrol: 470 Clinical Trials, Page 1 of 47
Hide Studies Not Open or Pending
2
Vivitrol Treatment for Cannabis Use Disorder
Condition(s):Cannabis Use DisorderLast Updated:September 25, 2020Not yet recruiting
3
Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
Condition(s):Opiate DependenceLast Updated:June 1, 2016Completed
4
Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
Condition(s):Opiate Dependence; Human Immunodeficiency VirusLast Updated:November 6, 2020Completed
5
Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
Condition(s):DepressionLast Updated:April 24, 2018Completed
6
Extended-release Naltrexone for Alcohol Dependence in Primary Care
Condition(s):Alcohol DependenceLast Updated:September 27, 2011Completed
7
Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence
Condition(s):Cannabis DependenceLast Updated:April 24, 2019Completed
8
Pre-Release VIVITROL for Opioid Dependent Inmates
Condition(s):Substance-Related DisordersLast Updated:October 22, 2015Completed
9
Evaluation of Naltrexone as a Treatment for Self-injurious Behavior
Condition(s):Self-injurious Behavior; Self MutilationLast Updated:November 6, 2017Withdrawn
10
Improved Strategies for Outpatient Opioid Detoxification
Condition(s):Opioid DependenceLast Updated:May 21, 2018Completed